A149 Procedureless Gastric Balloon for Weight Loss: Multi-Center Experience in 1623 Consecutive Patients

Show simple item record

dc.contributor.author Ienca, Roberta
dc.contributor.author Diaz, Adelardo
dc.contributor.author Giardiello, Cristiano
dc.contributor.author Rosa, Michele
dc.contributor.author Jarallah, Mohamad
dc.contributor.author Kolmer, Sebastian
dc.contributor.author Sebbag, Hugues
dc.contributor.author Hansoulle, Julie
dc.contributor.author Quartararo, Giovanni
dc.contributor.author Alzouaghi, Al
dc.contributor.author Kumar Juneja, Girish
dc.contributor.author Turro Arau, Roman
dc.contributor.author Pagan Pomar, Alberto
dc.contributor.author Badiuddin, Faruq
dc.contributor.author Dargent, Jerome
dc.contributor.author Durou, Jean
dc.contributor.author Urbain, Pierre
dc.contributor.author Paveliu, Stefan
dc.contributor.author Alkuwari, Mohammed
dc.date.accessioned 2020-02-04T11:14:12Z
dc.identifier.uri http://hdl.handle.net/11201/150811
dc.description.abstract [eng] Background The Elipse¿ Balloon has emerged as a novel, non-endoscopic option for patients with obesity or overweight. It is swallowed in an outpatient setting and filled with 550ml of fluid. After 4 months of gastric residence, the balloon spontaneously empties and is excreted naturally. Objective: To evaluate the safety and efficacy of the current generation Elipse Balloon in a large, multicenter, international population. Methods Outcomes data from 1623 consecutive Elipse Balloon patients (1171F/506M) treated in 19 centers across 7 countries were pooled for analysis. Nutritional counseling was provided. Data included weight loss, metabolic parameters, ease of placement, device performance, and complications. Results At placement, mean age was 39.2±12 yrs, mean weight 94±18.6 kg and mean BMI 34.2±5.4 kg/m2. Triglycerides, LDL cholesterol and HgB A1C were 144.6±70.8 mg/dl, 133.2±43.8 mg/dl and 5.1±1.2% respectively. After 4 months, TBWL was 13.6±5.7%. Mean WL, mean EWL and mean BMI reduction were 12.9±6.5 kg, 55.8±1.1% and 4.9±3.3 kg/m2 respectively. All metabolic parameters improved. 99.9% patients were able to swallow the device with 31.7% needing stylet assistance. Ten (0.62%) empty balloons were vomited and the rest were excreted in stool. Three (0.18%) balloons deflated early. 41 (2.5%) patients had intolerance requiring endoscopic balloon removal. One (0.06%) patient developed esophagitis. One (0.06%) had gastric perforation requiring surgery. There were no small bowel obstructions or any other serious complications. Conclusion The Elipse¿ Balloon demonstrated an excellent safety profile with no small bowel obstructions. The balloon also exhibited remarkable efficacy with 13.6% TBWL and improvement across all metabolic parameters.
dc.format application/pdf
dc.relation.isformatof Versió postprint del document publicat a: https://doi.org/10.1016/j.soard.2019.08.095
dc.relation.ispartof Surgery For Obesity And Related Diseases, 2019, vol. 15, num. 10, p. S33-S33
dc.subject.classification 614 - Higiene i salut pública. Contaminació. Prevenció d'accidents. Infermeria
dc.subject.classification 617 - Cirurgia. Ortopèdia. Oftalmologia
dc.subject.other 614 - Public health and hygiene. Accident prevention
dc.subject.other 617 - Surgery. Orthopaedics. Ophthalmology
dc.title A149 Procedureless Gastric Balloon for Weight Loss: Multi-Center Experience in 1623 Consecutive Patients
dc.type info:eu-repo/semantics/article
dc.type info:eu-repo/semantics/acceptedVersion
dc.date.updated 2020-02-04T11:14:12Z
dc.date.embargoEndDate info:eu-repo/date/embargoEnd/2026-12-31
dc.embargo 2026-12-31
dc.subject.keywords Balón intragástrico Elipse
dc.subject.keywords Balón Intragástrico
dc.subject.keywords sobrepeso
dc.subject.keywords Obesidad
dc.rights.accessRights info:eu-repo/semantics/embargoedAccess
dc.identifier.doi https://doi.org/10.1016/j.soard.2019.08.095

Files in this item

This item appears in the following Collection(s)

Show simple item record

Search Repository

Advanced Search


My Account